ERBB2 and breast cancer: We must take into account that multi-epitope-based vaccines are an interesting idea and could be helpful in those types of breast cancer with negative expression of HER2, to which in silico approaches emphasizing the search of immunogenic and antigenic sites in the TAA or TSA that we propose are needed.